| SLE group (n = 210) | Non-SLE group (n = 237) | Pvalue |
---|---|---|---|
Age (year, mean ± SD) | 71.5 ± 8.3 | 71.6 ± 9.2 | 0.892 (NS) |
Gender Man/Woman | 163 (77.6%)/47 (22.4%) | 172 (72.6%)/65 (27.4%) | 0.263 (NS) |
Tumor location | Â | Â | Â |
 U | 30 (14.3%) | 45 (19.0%) | 0.315 (NS) |
 M | 79 (37.6%) | 97 (40.9%) | 0.537 (NS) |
 L | 101 (48.1%) | 95 (40.1%) | 0.108 (NS) |
Macroscopic type | Â | Â | Â |
 Elevated type/Depressed type | 115 (54.8%)/95 (45.2%) | 132 (55.7%)/105 (44.3%) | 0.918 (NS) |
Tumor size | Â | Â | Â |
(mm, mean ± SD) | 16.5 ± 9.0 | 17.5 ± 11.8 | 0.309 (NS) |
Histopathology | Â | Â | Â |
 Adenoma/Carcinoma | 30 (14.3%)/180 (85.7%) | 41 (17.3%)/196 (82.7%) | 0.460 (NS) |
Depth of invasion | Â | Â | Â |
 M/SM | 189 (90.0%)/21 (10.0%) | 223 (94.1%)/14 (5.9%) | 0.152 (NS) |
Heart disease | 35 (16.7%) | 34 (14.3%) | 0.584 (NS) |
Renal disease | 7 (3.3%) | 14 (5.9%) | 0.289 (NS) |
Hepatic disease | 23 (11.0%) | 19 (8.0%) | 0.368 (NS) |
Pulmonary disease | 13 (6.2%) | 20 (8.4%) | 0.661 (NS) |
Brain disease | 24 (11.4%) | 18 (7.6%) | 0.221 (NS) |
Hypertension | 92 (43.8%) | 121 (51.1%) | 0.126 (NS) |
Diabetes mellitus | 36 (17.1%) | 38 (6.0%) | 0.851 (NS) |
Hyperlipidemia | 23 (11.0%) | 41 (17.3%) | 0.056 (NS) |